Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea. - Wikidata - awgldk - TriplyDB

Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea.

Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea.

http://www.wikidata.org/entity/Q36526459

about

Tailored treatment strategies for obstructive sleep apnea Obstructive sleep apnoea pathogenesis from mild to severe: Is it all the same?Should All Congestive Heart Failure Patients Have a Routine Sleep Apnea Screening? Con Quantifying the ventilatory control contribution to sleep apnoea using polysomnography.Treatment of Obstructive Sleep Apnea. Prospects for Personalized Combined Modality Therapy.Treatments for Obstructive Sleep Apnea Innovative treatments for adults with obstructive sleep apnea.Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea.Trazodone Effects on Obstructive Sleep Apnea and Non-REM Arousal Threshold.Increased Carbonic Anhydrase Activity is Associated with Sleep Apnea Severity and Related Hypoxemia.The Effect of Body Position on Physiological Factors that Contribute to Obstructive Sleep Apnea.Adaptive responses using obstructive sleep apnea as the paradigm.The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility.Alternative approaches to treatment of Central Sleep Apnea.Emerging drugs for common conditions of sleepiness: obstructive sleep apnea and narcolepsy.A resource of potential drug targets and strategic decision-making for obstructive sleep apnoea pharmacotherapy.Impact of concomitant medications on obstructive sleep apnoea.Central sleep apnoea in congestive heart failure.Update in respiratory sleep disorders: Epilogue to a modern review series.Effects of hyperoxia and hypoxia on the physiological traits responsible for obstructive sleep apnoea.Narrative review of contemporary treatment options in the care of patients with obstructive sleep apnoea.Phenotyping-based treatment improves obstructive sleep apnea symptoms and severity: a pilot study.Rebuttal from Magdy Younes.CrossTalk opposing view: Loop gain is not a consequence of obstructive sleep apnoea.Neurology and altitude illness.Effectiveness of a lightweight portable auto-CPAP device for the treatment of sleep apnea during high altitude stages of the Dakar Rally: a case report

P2860

Q26771548-1DC4EB9E-6A9B-44E2-99F5-C9FB29C8CD72 Q28078503-F8D86FA9-7540-4326-B2C8-31C9922542F9 Q28083056-9EBC2CAD-389B-41F0-9E5D-C4CD5C44B28B Q30405667-3C718F67-E265-4C53-93D1-2CEBF8C52917 Q33772394-63891581-7987-4B5E-A1DD-18E59EFFA6D9 Q34524490-8DAB5AE9-F7A4-4754-917E-7C076332F818 Q34566345-7706F93F-2FAD-4140-ADD3-A7A7E7074202 Q34986911-5F35B950-923A-4C34-A070-BA7567914BA6 Q35565139-DCAAEF53-1741-4FF1-B30D-6E17DBFAA431 Q35782384-3717AFEF-0100-480D-8EDB-3DD5F0138842 Q35936381-FB89DC5D-39B8-48D0-A240-A60F77FC1716 Q36956274-D05AF1EF-221C-4325-9C6D-D9EE5DF54754 Q37351255-5785E11E-FC68-4243-9BB7-F0BD25A36CB6 Q37720626-2E6A76FD-52DE-4B70-8D0B-26E2A75E5379 Q38630470-BB1D9084-90B4-4BC4-B454-8A501CED98C7 Q38679035-D808E5D8-0A48-40B7-838B-E22B956E249A Q38979483-8A69F544-8347-4519-A156-3F249B13ECDF Q40705065-F5A714C5-9DCD-4AC5-8F06-A3A47B4A3998 Q46220375-0095C9DA-42A8-4197-995F-E595153FE3C1 Q46302003-AF663674-EC24-4697-BF57-E6D0E23F8C50 Q47670552-83D8510A-CC19-4535-AC2F-1390F6DDFB52 Q47760039-CBB771D4-BD5F-4835-8982-6735C03B4EDD Q48093820-756C8CBF-9BA4-470F-90DD-B618489B11E0 Q48093832-91218218-A981-4424-9AD3-B5AEC074B36F Q49332994-49B755AC-5575-469B-92BB-3F00113179C2 Q57093115-64BC3394-B93B-4636-B853-24E91DE2C903

P2860

Acetazolamide attenuates the ventilatory response to arousal in patients with obstructive sleep apnea.

http://www.wikidata.org/entity/Q36526459

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Acetazolamide attenuates the v ...... with obstructive sleep apnea.

@ast

Acetazolamide attenuates the v ...... with obstructive sleep apnea.

@en

type

label

Acetazolamide attenuates the v ...... with obstructive sleep apnea.

@ast

Acetazolamide attenuates the v ...... with obstructive sleep apnea.

@en

prefLabel

Acetazolamide attenuates the v ...... with obstructive sleep apnea.

@ast

Acetazolamide attenuates the v ...... with obstructive sleep apnea.

@en

P1433

Q36526459-B792E9B9-DDA1-4956-BC83-22A87D0EB7EE

P1476

Q36526459-E5E808F7-6569-44D4-BDFF-44B8E3EADEA8

P2093

Q36526459-15CA6DD8-3361-43E9-B7D7-1292AA8960AA

Q36526459-232F072E-38BC-4BA6-8C78-7A79EC297F59

Q36526459-446B0B1A-4D0D-4B21-B0F2-A7DB3C2D254F

Q36526459-63E98D80-F3C6-42A6-BFC9-D3AD0756B55B

Q36526459-AAFCF1F7-9DBB-4BC4-8E25-FFEFE31AF6BA

Q36526459-C6811252-FAB7-43FD-9574-B3A58814DDAE

Q36526459-DD1A57A3-329D-442F-B67E-F11B42078032

Q36526459-FD73B490-EB51-4976-BF52-E7BC2EE7D6BF

P2860

Q36526459-02E419A5-53F2-466F-BB46-F9B2B9CFA172

Q36526459-141668F2-4454-4E0A-A61B-2AF450E52949

Q36526459-2A3AE7B1-2C3E-42B1-BC48-3F2EE7AE6CB2

Q36526459-35486A09-8485-4F5E-884F-69BE8582C8D6

Q36526459-36F3D54E-6FEC-400B-A5B7-7C49BBA6C729

Q36526459-93AE2D74-B1C5-4E0C-996B-2E8F3A9F2236

Q36526459-9D49B5C9-8518-4463-AEA9-67B1081EFFDC

Q36526459-A13F9EE6-22E0-4052-B2D9-BD46DC9492EB

Q36526459-A9CA30D9-D7E9-49EC-9C3B-4BD7FB254200

Q36526459-D566A4B4-630D-4EE3-BC7F-3557342C75E2

P304

Q36526459-28FAE279-2823-422B-9813-94903F9CC961

P31

Q36526459-84C875B3-4368-43EF-AEDB-8C2CEE256C67

P356

Q36526459-3BEC7FF4-E3E0-40E6-9326-931412A9A6FA

P433

Q36526459-8FFD0B1A-37F3-44FD-8F90-7CEB4F1FF734

P478

Q36526459-B0DB39E6-B1B9-45D4-AEB0-D3CFF5FA0FB9

P577

Q36526459-5EA105CC-6413-49CF-9E8F-426EEED0ED10

P5875

Q36526459-7DE5111F-FEC7-4421-8FE7-329748D099CA

P698

Q36526459-58E41FFA-5729-490E-B21E-EB0324DD7570

P932

Q36526459-28875227-B248-4DE6-99FE-B19B9F916F94

P356

P1433

P1476

Acetazolamide attenuates the v ...... with obstructive sleep apnea.

@en

P2093

Andrew Wellman

http://www.w3.org/2001/XMLSchema#string

Atul Malhotra

http://www.w3.org/2001/XMLSchema#string

Bradley A Edwards

http://www.w3.org/2001/XMLSchema#string

David P White

http://www.w3.org/2001/XMLSchema#string

James G Connolly

http://www.w3.org/2001/XMLSchema#string

John A Trinder

http://www.w3.org/2001/XMLSchema#string

Lisa M Campana

http://www.w3.org/2001/XMLSchema#string

Scott A Sands

http://www.w3.org/2001/XMLSchema#string

P2860

The occurrence of sleep-disordered breathing among middle-aged adults

Termination of respiratory events with and without cortical arousal in obstructive sleep apnea.

Increased propensity for central apnea in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure.

Determinants of ventilatory instability in obstructive sleep apnea: inherent or acquired?

Control of breathing during sleep.

Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea.

Acetazolamide on the ventral medulla of the cat increases phrenic output and delays the ventilatory response to CO2.

Ventilatory dynamics during transient arousal from NREM sleep: implications for respiratory control stability.

Ventilatory dynamics of transient arousal in patients with obstructive sleep apnea.

The influence of gender and upper airway resistance on the ventilatory response to arousal in obstructive sleep apnoea in humans.

P304

281-285

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5665/SLEEP.2390

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235392963

http://www.w3.org/2001/XMLSchema#string

P698

23372276

http://www.w3.org/2001/XMLSchema#string

P932

3543060

http://www.w3.org/2001/XMLSchema#string